Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease

Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease
复制标题

DOI:
10.1016/j.ekir.2018.04.002
复制
发表时间:
2018-04-16
影响因子:
6
通讯作者:
Kashihara N
Kashihara N
中科院分区:
医学2区
文献类型:
--
作者:
Kume S;Nagasu H;Nangaku M;Nishiyama A;Nakamoto H;Kashihara N

文献摘要

参考文献

被引文献

相似文献

国际肾脏病学会(ISN)前沿会议通过将基础科学家、临床医生和从业者聚集在一个独特的环境中,建立在ISN Nexus和Foreronts系列成功的基础上。组织这一新活动的目的是通过消除获取最新知识的地区障碍,向全球受众提供更多创新科学。第一次IS前沿会议是由日本肾病学会和日本透析疗法学会合作举办的,于2018年2月在东京举行。会议的主题是“肾脏疾病和心血管疾病”,涵盖了广泛的科学和临床领域,包括肾脏病、心血管疾病、透析、移植、慢性肾脏病(CKD)-矿物性骨病(MBD)、糖尿病、儿科肾病、营养学、药理学和护理。来自国家的1,584名现役医生和科学家参加了会议,来自临床和基础研究不同学科和相关学科的多位顶尖内科科学家介绍和回顾了最近的发现。本报告总结了会议讲座的主要亮点。
International Society of Nephrology (ISN) Frontiers meetings build on the success of the ISN Nexus and Forefronts series by bringing together basic scientists, clinicians, and practitioners in a unique setting. This new event was organized to make more innovative science available to a global audience by removing regional barriers in accessing the latest knowledge. The first ISN Frontiers meeting was organized in partnership between the Japanese Society of Nephrology and the Japanese Society for Dialysis Therapy, which was held in Tokyo in February 2018. The meeting focused on the topic “Kidney Disease & Cardiovascular Disease,” which covered a broad range of scientific and clinical fields, including nephrology, cardiovascular diseases, dialysis, transplantation, chronic kidney disease (CKD)–mineral bone disease (MBD), diabetes, pediatric nephrology, nutrition, pharmacology, and nursing. A total of 1584 active physicians and scientists from 64 countries attended the meeting, and a number of leading physician scientists from different and related disciplines of clinical and basic research described and reviewed recent discoveries. This report summarizes the main highlights of the meeting lectures.
DOI: 10.1056/nejmoa0706130
发表时间: 2008-08-07
期刊: The New England journal of medicine
影响因子: --
作者:
Gutiérrez OM;Mannstadt M;Isakova T;Rauh-Hain JA;Tamez H;Shah A;Smith K;Lee H;Thadhani R;Jüppner H;Wolf M
通讯作者: Wolf M
DOI: 10.1056/nejmoa1306033
发表时间: 2013-12-26
期刊: The New England journal of medicine
影响因子: --
作者:
de Zeeuw D;Akizawa T;Audhya P;Bakris GL;Chin M;Christ-Schmidt H;Goldsberry A;Houser M;Krauth M;Lambers Heerspink HJ;McMurray JJ;Meyer CJ;Parving HH;Remuzzi G;Toto RD;Vaziri ND;Wanner C;Wittes J;Wrolstad D;Chertow GM;BEACON Trial Investigators
通讯作者: BEACON Trial Investigators
DOI: 10.1053/j.ajkd.2016.08.018
发表时间: 2017-01-01
影响因子: 13.2
作者:
Hiremath, Swapnil;Fergusson, Dean A.;Knoll, Greg A.
通讯作者: Knoll, Greg A.
DOI: 10.1111/dom.13041
发表时间: 2017-11
期刊: Diabetes, obesity & metabolism
影响因子: --
作者:
Groop PH;Cooper ME;Perkovic V;Hocher B;Kanasaki K;Haneda M;Schernthaner G;Sharma K;Stanton RC;Toto R;Cescutti J;Gordat M;Meinicke T;Koitka-Weber A;Thiemann S;von Eynatten M
通讯作者: von Eynatten M